Dewpoint Therapeutics, Inc.

Industry: Biotechnology (See others in industry)

Address:

451 D Street, Suite 104
Boston, MA, 02210
Phone: 617-914-8448

Filings

Date	FilingType	Reported Sold	Incremental Cash	Type	Exemptions	Link to Raw Filing
2025-09-23	New	$59,124,298	$59,124,298	Equity Only	06b	SEC link
2022-02-04	New	$149,999,989	$149,999,989	Equity Only	06b	SEC link
2020-11-02	New	$77,097,477	$77,097,477	Equity Only	06b	SEC link

Directors and Executives (Current and Past)

Name	Role
Srinivas Akkaraju, M.D.	Director
Srinivas Akkaraju, M.D., Ph.D.	Director
Regina Barzilay, Ph.D.	Director
Bruce Beutel	Executive
Olivier Brandicourt, M.D.	Director
Oliver Brandicourt, M.D.	Director
Guiseppe A. Ciaramella, Ph,D.	Director
Giuseppe Ciaramella, Ph.D.	Director
Giuseeppe Ciaramella, Ph.D.	Director
Jurgen Eckhardt, M.D.	Director
Juergen Eckhardt, M.D.	Director
Lori Escobedo	Executive
Anthony A. Hyman, Ph.D.	Director
Isaac A. Klein, M.D., Ph.D.	Executive
Elisabeth Leiderman	Executive
Mark Murcko, Ph.D.	Director
Amir H. Nashat	Director
Amir H. Nashat, Ph.D.	Director
Ameet Nathwani, M.D.	Director, Executive
Fabio Pucci, Ph.D.	Director
Joel D. Sendek	Executive
Richard A. Young, Ph.D.	Director